VANGUARD GROUP INC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$152,356,166
+21.5%
3,012,182
+12.1%
0.00%
+33.3%
Q2 2023$125,403,458
+53.2%
2,685,874
+25.6%
0.00%
+50.0%
Q1 2023$81,834,046
-29.4%
2,138,893
+1.1%
0.00%
-33.3%
Q4 2022$115,988,091
+95.7%
2,116,571
+21.6%
0.00%
+50.0%
Q3 2022$59,267,000
+378.4%
1,740,593
+32.8%
0.00%
Q2 2022$12,389,000
-28.8%
1,311,014
+6.9%
0.00%
Q1 2022$17,410,000
-29.7%
1,226,911
+4.8%
0.00%
-100.0%
Q4 2021$24,755,000
+2.5%
1,170,419
+8.3%
0.00%0.0%
Q3 2021$24,151,000
-8.1%
1,080,585
+2.0%
0.00%0.0%
Q2 2021$26,290,000
-8.1%
1,059,636
+7.5%
0.00%0.0%
Q1 2021$28,595,000
+25.4%
985,720
+11.6%
0.00%0.0%
Q4 2020$22,796,000
-13.3%
883,563
+3.5%
0.00%0.0%
Q3 2020$26,288,000
+95.3%
853,773
+58.1%
0.00%
Q2 2020$13,459,000
+107.0%
540,076
+76.1%
0.00%
Q1 2020$6,503,000
+3.0%
306,719
+7.8%
0.00%
Q4 2019$6,316,000
+50.5%
284,596
+54.2%
0.00%
Q3 2019$4,198,000
+631.4%
184,525
+515.1%
0.00%
Q2 2019$574,00030,0000.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders